Analytical Data
-
基因名
GLT1D1
- Application
-
别名
GLT1D1Glycosyltransferase 1 domain-containing protein 1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96MS3
-
表达区间
1-266aa
-
氨基酸序列
MRLLFLAVLRPHTGNAVTAQRVRAHLEAAGHVCVLKDAFDFESRSEIANLILAENCEAALALHLYRGGRLLQGHRIPFGVIFGGTDVNEDANQAEKNTVMGRVLEEARFAVAFTESMKEMAQAQWVDPVFTREVKAKVKRAAGVRLIGEMPQEDLHAVVKNCFAVVNSSVSEGMSAAILEAMDLEVPVLARNIPGNAAVVKHEVTGLLFSNPQEFVHLAKRLVSDPALEKEIVVNGREYVRMYHSWQVERDTYQQLIRKLEGSTED
-
分子量
55.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GLT1D1 recombination protein has garnered significant attention in the field of molecular biology due to its potential role in various physiological processes and pathological conditions. This protein is part of a larger family of glutamate transporters, essential for maintaining synaptic transmission and glutamate homeostasis in the central nervous system. Dysregulation of glutamate levels is implicated in a range of neurological disorders, including epilepsy, schizophrenia, and neurodegenerative diseases. Therefore, investigating the properties and functions of GLT1D1 not only enhances our understanding of glutamate transport mechanisms but also aids in identifying novel therapeutic targets for these conditions. Recombinant expression of GLT1D1 allows for detailed functional assays and structural studies, which are crucial for elucidating the protein's role in cellular processes. Moreover, advancing our knowledge of GLT1D1 may contribute to the development of innovative strategies for treating synaptic dysfunction and related disorders, highlighting the importance of this research in both basic and applied biomedical sciences.
